申请人:Cylene Pharmaceuticals, Inc.
公开号:US08124649B2
公开(公告)日:2012-02-28
The invention provides compounds that inhibit PIM kinases and Flt3 kinase, and compositions containing such compounds. These compounds and compositions are useful for treating proliferative disorders such as cancer, as well as other kinase-associated conditions including inflammation.
本发明提供了抑制PIM激酶和Flt3激酶的化合物以及含有这些化合物的组合物。这些化合物和组合物可用于治疗增殖性疾病,如癌症,以及其他与激酶相关的疾病,包括炎症。